gyki 53655 has been researched along with 2-amino-5-phosphonovalerate in 12 studies
| Studies (gyki 53655) | Trials (gyki 53655) | Recent Studies (post-2010) (gyki 53655) | Studies (2-amino-5-phosphonovalerate) | Trials (2-amino-5-phosphonovalerate) | Recent Studies (post-2010) (2-amino-5-phosphonovalerate) |
|---|---|---|---|---|---|
| 111 | 0 | 22 | 4,393 | 1 | 539 |
| Protein | Taxonomy | gyki 53655 (IC50) | 2-amino-5-phosphonovalerate (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.29 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banczerowski-Pelyhe, I; Csúcs, G; Tarnawa, I; Világi, I | 1 |
| Collingridge, GL; Vignes, M | 1 |
| Banczerowski-Pelyhe, I; Kocsis, P; Tarnawa, I; Világi, I | 1 |
| Ben-Ari, Y; Chevassus-Au-Louis, N; Diabira, D; Gozlan, H; Hennou, S | 1 |
| Lerma, J; López-García, JC; Rodríguez-Moreno, A | 1 |
| Bleakman, D; Bortolotto, ZA; Collingridge, GL; Isaac, JT; Lauri, SE; Lodge, D; Ornstein, PL | 1 |
| Heggelund, P; Kielland, A | 1 |
| Ali, AB | 1 |
| Clarke, VR; Collingridge, GL | 1 |
| Breustedt, J; Schmitz, D | 1 |
| Chen, T; Kaang, BK; Koga, K; Sim, SE; Wu, LJ; Zhuo, M | 1 |
| Jiang, L; Kang, D; Kang, J | 1 |
12 other study(ies) available for gyki 53655 and 2-amino-5-phosphonovalerate
| Article | Year |
|---|---|
An increased intensity of N-methyl-D-aspartate (NMDA) but not non-NMDA receptor activation may be responsible for the enhancement of excitatory processes in the neocortex of two-week-old rats: a brain slices study.
Topics: Action Potentials; Animals; Animals, Suckling; Benzodiazepines; Binding, Competitive; Cerebral Cortex; Electric Stimulation; Excitatory Amino Acid Antagonists; Organophosphonates; Pentanoic Acids; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Somatosensory Cortex; Synaptic Transmission; Valine | 1996 |
The synaptic activation of kainate receptors.
Topics: 2-Amino-5-phosphonovalerate; Aminoquinolines; Animals; Benzodiazepines; Bicuculline; Evoked Potentials; Excitatory Amino Acid Antagonists; GABA Antagonists; Hippocampus; In Vitro Techniques; Picrotoxin; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid; Synapses | 1997 |
Effect of glutamate receptor antagonists on excitatory postsynaptic potentials in striatum.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Benzodiazepines; Corpus Striatum; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; Male; Organ Culture Techniques; Rats; Rats, Inbred Strains; Receptors, Glutamate | 1998 |
Late embryonic expression of AMPA receptor function in the CA1 region of the intact hippocampus in vitro.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Afferent Pathways; Aging; Animals; Animals, Newborn; Benzodiazepines; Bicuculline; Cations, Divalent; Electric Stimulation; Embryonic and Fetal Development; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Fluorescent Dyes; Hippocampus; Hypoxia; Lysine; Pyramidal Cells; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Synapses; Tetrodotoxin | 1999 |
Two populations of kainate receptors with separate signaling mechanisms in hippocampal interneurons.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzodiazepines; Bicuculline; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Indoles; Interneurons; Isoxazoles; Kainic Acid; Lidocaine; Maleimides; Naphthalenes; Nerve Tissue Proteins; Patch-Clamp Techniques; Propionates; Protein Kinase C; Pyramidal Cells; Rats; Rats, Wistar; Receptors, Kainic Acid; Receptors, Presynaptic; Signal Transduction; Staurosporine; Virulence Factors, Bordetella | 2000 |
A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP.
Topics: 2-Amino-5-phosphonovalerate; Animals; Benzodiazepines; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; In Vitro Techniques; Isoquinolines; Long-Term Potentiation; Mossy Fibers, Hippocampal; Rats; Receptors, Kainic Acid; Receptors, Presynaptic; Synapses; Synaptic Transmission | 2001 |
AMPA receptor properties at the synapse between retinal afferents and thalamocortical cells in the dorsal lateral geniculate nucleus of the rat.
Topics: 2-Amino-5-phosphonovalerate; Animals; Antihypertensive Agents; Benzodiazepines; Benzothiadiazines; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Geniculate Bodies; Membrane Potentials; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, AMPA; Retinal Ganglion Cells; Synapses; Visual Cortex; Visual Pathways | 2001 |
Involvement of post-synaptic kainate receptors during synaptic transmission between unitary connections in rat neocortex.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Antihypertensive Agents; Benzodiazepines; Benzothiadiazines; Dicarboxylic Acids; Drug Interactions; Electric Conductivity; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; In Vitro Techniques; Membrane Potentials; Neocortex; Neural Pathways; Neurotransmitter Uptake Inhibitors; Patch-Clamp Techniques; Pyramidal Cells; Pyrrolidines; Rats; Rats, Wistar; Receptors, Kainic Acid; Synaptic Transmission; Time Factors; Valine | 2003 |
Characterisation of the effects of ATPA, a GLU(K5) kainate receptor agonist, on GABAergic synaptic transmission in the CA1 region of rat hippocampal slices.
Topics: Animals; Benzodiazepines; Dose-Response Relationship, Drug; Drug Interactions; Electric Impedance; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Agents; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; In Vitro Techniques; Isoxazoles; Kainic Acid; Membrane Potentials; Neural Inhibition; Propionates; Pyramidal Cells; Rats; Rats, Wistar; Receptors, Kainic Acid; Synaptic Transmission; Valine | 2004 |
Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids, Dicarboxylic; Animals; Benzodiazepines; Cyclopropanes; Excitatory Postsynaptic Potentials; Gene Deletion; GluK2 Kainate Receptor; Glycine; Isoquinolines; Isoxazoles; Kainic Acid; Mice; Mice, Knockout; Mossy Fibers, Hippocampal; Neuronal Plasticity; Patch-Clamp Techniques; Potassium; Propionates; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Kainic Acid; Synaptic Transmission | 2004 |
Kainate receptor-mediated synaptic transmissions in the adult rodent insular cortex.
Topics: 2-Amino-5-phosphonovalerate; Alanine; Animals; Benzodiazepines; Cerebral Cortex; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; GluK2 Kainate Receptor; Mice; Mice, Inbred C57BL; Mice, Knockout; Picrotoxin; Pyramidal Cells; Receptors, Kainic Acid; Synaptic Transmission; Thymine | 2012 |
Potentiation of tonic GABAergic inhibition by activation of postsynaptic kainate receptors.
Topics: Action Potentials; Animals; Animals, Newborn; Benzodiazepines; Biophysics; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GABA Agents; GABAergic Neurons; Hippocampus; Humans; In Vitro Techniques; Kainic Acid; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Tetrodotoxin; Valine | 2015 |